Lys Therapeutics announces €2 million grant from BpifranceLys Therapeutics announces €2 million grant from BpifranceThis site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyParametersWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.
If you do not want that we track your visit to our site you can disable tracking in your browser here:
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
The following cookies are also needed - You can choose if you want to allow them:
✨Thrilled to share that, starting #tomorrow, Lys Therapeutics will be participating in the prestigious #Jefferies 2023 London Healthcare Conference from November 14 to November 16, 2023, hosted at the Waldorf Hilton hotel. 🌍
🚀 Lys Therapeutics is at the forefront of revolutionizing the treatment landscape for unmet medical needs in patients facing neurovascular or neurodegenerative disorders. Our focus on addressing blood-brain barrier dysfunction opens new avenues for transformative solutions.
🔬 We believe in the power of innovation to make a real impact on patients’ lives. Our commitment to pioneering approaches aligns seamlessly with the spirit of this conference, and we’re ready to explore synergies that drive progress in healthcare.
🤝 Looking forward to engaging conversations, forging valuable connections, and sharing insights into our groundbreaking work. Stay tuned for updates from the conference as we continue our journey toward transforming the future of healthcare. 💡
With David Soria, Clément Boucher, Gil Bar-Nahum, PhD, Marco Baruzzi
#LysTherapeutics #JefferiesHealthcare #Partnering #Biotech #CNS